Evidence map›Paper›PMID 36476448›Full record

Observational studyBMC infectious diseases2022

Impact of antimicrobial stewardship on antibiogram, consumption and incidence of multi drug resistance.

Rula M Darwish, Sajeda Ghassan Matar, Ahmad Atef Abu Snaineh, Mohammad Refat Alsharif, Ahmad Bassam Yahia, Haneen Nidal Mustafa, Elfatih A Hasabo

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Emergence and Genomic Characterization of aMedicina (Kaunas, Lithuania) · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Rula M DarwishDepartment of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman, Jordan.ORCID http://orcid.org/0000-0003-2359-676X
Sajeda Ghassan MatarFaculty of Pharmacy, Applied Science Private University, Amman, Jordan.ORCID http://orcid.org/0000-0002-3642-5700
Ahmad Atef Abu SnainehIstishari Hospital, Amman, Jordan.ORCID http://orcid.org/0000-0002-3519-1471
Mohammad Refat AlsharifIstiklal Hospital Lab, Istiklal Hospital, Amman, Jordan.ORCID http://orcid.org/0000-0002-1230-5536
Ahmad Bassam YahiaJordanian Ministry of Health, Amman, Jordan.ORCID http://orcid.org/0000-0002-7984-0656
Haneen Nidal MustafaFaculty of Pharmacy, Applied Science Private University, Amman, Jordan.ORCID http://orcid.org/0000-0003-0347-9654
Elfatih A HasaboFaculty of Medicine, University of Khartoum, Khartoum, Sudan. elfatih.ahmed.hasabo@gmail.com.ORCID http://orcid.org/0000-0001-9727-8620
University of Jordan · JOJordan Hospital · JOMinistry of Health · JOUniversity of Khartoum · SD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntimicrobial stewardship programs are intended to improve patient outcomes, reduce side effects, bacterial resistance, and costs. Thus, it is important to assess their impact on an ongoing basis. We aimed to assess the impact of the antimicrobial stewardship program in two different hospitals which used different program approaches. METHODOLOGY: This is a retrospective observational study in two private hospitals [4088 patient records] in Amman- Jordan. Antibiotic susceptibility using antibiogram results, consumption of antibiotics using Defined Daily Dose, and the incidence of Multi-Drug Resistance were recorded using patients' records during 2018, 2019, and 2020.

resultsAntimicrobial stewardship program outcomes varied between the two hospitals. Bacterial susceptibility to antibiotics were improved in both hospitals. Moreover, the defined daily dose in Hospital "A" showed no significant change in Fluoroquinolones, Carbapenems, and Piperacillin- Tazobactam, Cephalosporins, and Colistin, while a significant change was observed among Anti-MRSA antibiotics. Finally, the incidence of Extended Spectrum Beta-lactamase [ESBL] E. coli, ESBL Klebsiella, and Vancomycin Resistant Enterococci [VRE] have decreased numerically over the study period, while Methicillin-Resistant Staphylococcus aureus [MRSA] showed an increase in incidence during the second year of the study.

conclusionThe study emphasizes the positive impact of the AMS program throughout the three years of the study. Plus, the need to enhance the program through recruiting extra staff and applying extra regulations like implementing educational programs for the hospital staff, designing local guidelines for common ID diseases, and monitoring the program's outcomes which would eventually be more efficient, cost-effective, and safe.

Indexed as

Antimicrobial StewardshipMethicillin-Resistant Staphylococcus aureusDrug Resistance, MultipleEscherichia coliHumansJordanAntibiogramAntibiotic resistanceAntibioticsAntimicrobial stewardship programDefined Daily DoseESBL E. coliESBL KlebsiellaMRSAMulti-drug resistanceVRE

Identifiers

PMID36476448
PMCPMC9730561
OpenAlexW4311574971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.